Clinical Trial Update: Effect of Denileukin Diftitox on Immune System in CTCL Patients

View source ↗

Summary

This completed trial update reports on the effects of denileukin diftitox on the immune system in patients with cutaneous T-cell lymphoma, including Sézary synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• ONTAK (denileukin diftitox)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cutaneous T-cell Lymphoma, Sezary Syndrome | Status: COMPLETED